Even though AR is expressed in over 70% of estrogen receptor (ER)-positive and in up to 45% of triple-negative breast cancer (TNBC), its role in breast cancer (BC) has not been completely elucidated. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.